Jump to content
Wikipedia The Free Encyclopedia

Lucid-PSYCH

From Wikipedia, the free encyclopedia
Pharmaceutical compound
Lucid-PSYCH
Clinical data
Other namesLUCID-PSYCH; Lucid-201
Drug class Undefined; Psychedelic; Hallucinogen

Lucid-PSYCH, or LUCID-PSYCH, also known as Lucid-201, is a psychedelic hallucinogen which is under development for the treatment of major depressive disorder.[1] [2] [3] [4] [5] It is under development by Lucid Psycheceuticals.[1] [2] Lucid-PSYCH's exact mechanism of action is undefined.[1] [2] As of March 2023, it is in preclinical research and is progressing to phase 1 clinical trials.[1] [2] [6]

See also

[edit ]

References

[edit ]
  1. 1 2 3 4 "Lucid PSYCH - AdisInsight". adisinsight.springer.com.
  2. 1 2 3 4 "Delving into the Latest Updates on Lucid-201 with Synapse". Synapse. 23 January 2025. Retrieved 16 February 2025.
  3. "Mental health disorders | Neurodegenerative disorders | Toronto". Archived from the original on 2022年05月31日.
  4. "Our Science". Archived from the original on 2023年06月05日.
  5. https://www.sec.gov/Archives/edgar/data/1771885/000115752321001089/a52478064_ex991.htm "Lucid’s pipeline includes Lucid-201, a psychedelic drug candidate targeting mental health disorders, [...]"
  6. "Registration". ANZCTR. Retrieved 16 February 2025.
Stub icon

This hallucinogen-related article is a stub. You can help Wikipedia by adding missing information.

AltStyle によって変換されたページ (->オリジナル) /